Massive Bio, Inc.
Massive Bio is an AI-powered precision medicine platform transforming how cancer patients access clinical trials worldwide by partnering with healthcare systems, pharmaceutical companies, and CROs. The company focuses on expanding access to innovative cancer treatments and improving trial enrollment efficiency.
Massive Bio is a healthcare technology company that uses AI-driven cancer analysis and clinical trial matching to connect oncology patients with appropriate investigational therapies. Their platform integrates clinical and genomic data to identify and prioritize trial matches, streamline referrals, and simplify enrollment workflows for hospitals, cancer centers, and life‑science sponsors. The company also offers patient navigation, molecular tumor board support, and site activation services to improve the patient experience and boost trial accrual. Massive Bio works with health systems, biopharma, and CRO partners to accelerate precision oncology research and broaden access to clinical trials.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Massive Bio, Inc..
3% below the average for this role
Senior Clinical Trials Specialist (Biotechnology Oncology)
Exelixis
Oncology Clinical Trials Coordinator
University of North Carolina System
Oncology Clinical Trials RN
Eden Capital Careers
Senior Pharmacist - Oncology Clinical Trials
The Royal Children's Hospital
Clinical Trials Manager
oraclecloudinfrastructure
Clinical Trials Manager
oraclecloudinfrastructure